Increased investment in thoracic surgical expertise increased UK lung cancer resection rate
Increased investment in specialist thoracic surgical expertise can lead to a significant rise in the lung cancer resection rate, based on data from England between 2008 and 2009 that was presented at the 14th World Conference on Lung Cancer in Amsterdam, hosted by the International Association for the Study of Lung Cancer (IASLC). In England, lung cancer resection is less common than in other countries, and is performed by both cardiothoracic and pure thoracic surgeons. Researchers tested the hypotheses that resection rate was related to the caseload and local provision of pure thoracic surgeons, and that expansion of thoracic surgery could increase the resection rate.
In 2008, 31 units provided the thoracic surgery service to 33 cancer networks comprising 174 trusts. Of these, 13 units (42%) had two or more pure thoracic surgeons. In 2009 this grew to 18 units (58%).
In 2008, there were 15,774 recorded cases of confirmed non-small cell lung cancer (NSCLC). Of these, 2,240 (14.2%) patients underwent surgical resection. In 2009, following the new consultant appointments, the number of histologically confirmed NSCLC increased by 13.8%, from 15,774 to 17,948 cases. The overall resection rate increased by 46% (from 14.2% to 20.7%).
In trusts where a pure thoracic surgeon was present in more than two-thirds of the lung cancer multidisciplinary team meetings, the NSCLC resection rate was significantly higher than those with lower attendance (median 14.7% vs 11.7%). Networks that experienced an expansion in their number of pure thoracic surgeons during this period experienced a significant and larger increase in resection rate than those who did not (median 66.3% vs 19%).
Source: International Association for the Study of Lung Cancer
Articles on the same topic
- TEMLA shows higher diagnostic yield than EBUS or EUS in largest reported series to dateThu, 7 Jul 2011, 8:33:38 UTC
- Endosonography followed by surgical staging improves quality of life, according to ASTER studyThu, 7 Jul 2011, 8:33:26 UTC
- Cancer patients with blood clots gain no benefit from adding IVCF to fondaparinuxThu, 7 Jul 2011, 8:33:16 UTC
- TGen presents lung cancer studies at Amsterdam conferenceThu, 7 Jul 2011, 7:33:39 UTC
- Canada's Cancer Risk Management model is an important new health tool for policymakersWed, 6 Jul 2011, 8:33:41 UTC
- Women, elderly, minorities poorly represented in lung cancer drug trial data submitted to US FDAWed, 6 Jul 2011, 8:33:31 UTC
- Elderly Dutch lung patients' survival improved by new treatment options between 2003-2009Wed, 6 Jul 2011, 8:33:06 UTC
- First whole-genome lung cancer study by TGen and Virginia G. Piper Cancer Center set for conferenceWed, 6 Jul 2011, 7:35:20 UTC
- Celecoxib may prevent lung cancer in former smokersWed, 6 Jul 2011, 4:33:12 UTC
- High EGFR expression a predictor for improved survival with cetuximab plus chemotherapy Tue, 5 Jul 2011, 9:02:35 UTC
- ALK rearrangement found in nearly 10 percent of patients in Lung Cancer Mutation ConsortiumTue, 5 Jul 2011, 9:02:25 UTC
- Lung tumors in never-smokers show greater genomic instability than those in smokersTue, 5 Jul 2011, 9:02:15 UTC
- EURTAC Phase III study: Erlotinib nearly doubles progression-free survival vs. chemotherapyTue, 5 Jul 2011, 9:02:06 UTC
- PET scan with [11C]erlotinib may provide noninvasive method to identify TKI-responsive lung tumorsTue, 5 Jul 2011, 9:01:57 UTC
Other sources
- Endosonography followed by surgical staging improves quality of life, according to new studyfrom Science DailyThu, 7 Jul 2011, 14:30:50 UTC
- TEMLA shows higher diagnostic yield than EBUS or EUS in largest reported series to datefrom PhysorgThu, 7 Jul 2011, 11:00:24 UTC
- Endosonography followed by surgical staging improves quality of life, according to ASTER studyfrom PhysorgThu, 7 Jul 2011, 11:00:22 UTC
- Cancer patients with blood clots gain no benefit from adding IVCF to fondaparinuxfrom PhysorgThu, 7 Jul 2011, 11:00:21 UTC
- TGen presents lung cancer studies at Amsterdam conferencefrom PhysorgThu, 7 Jul 2011, 8:01:37 UTC
- Celecoxib may prevent lung cancer in former smokersfrom Science DailyWed, 6 Jul 2011, 20:32:45 UTC
- Women, elderly, minorities poorly represented in lung cancer drug trial data submitted to US FDAfrom PhysorgWed, 6 Jul 2011, 14:30:50 UTC
- Canada's Cancer Risk Management model is an important new health tool for policymakersfrom PhysorgWed, 6 Jul 2011, 14:30:49 UTC
- Elderly Dutch lung patients' survival improved by new treatment options between 2003-2009from PhysorgWed, 6 Jul 2011, 14:01:53 UTC
- Increased investment in thoracic surgical expertise increased UK lung cancer resection ratefrom PhysorgWed, 6 Jul 2011, 14:01:45 UTC
- Celecoxib may prevent lung cancer in former smokersfrom PhysorgWed, 6 Jul 2011, 7:30:43 UTC
- First whole-genome lung cancer study set for conferencefrom PhysorgWed, 6 Jul 2011, 7:30:31 UTC
- Drug may prevent lung cancer in former smokersfrom Science BlogWed, 6 Jul 2011, 4:30:47 UTC
- ALK rearrangement found in nearly 10 percent of patients in Lung Cancer Mutation Consortiumfrom Science DailyTue, 5 Jul 2011, 14:31:06 UTC
- Lung tumors in never-smokers show greater genomic instability than those in smokersfrom Science DailyTue, 5 Jul 2011, 14:31:05 UTC
- PET scan with [11C]erlotinib may provide noninvasive method to identify TKI-responsive lung tumorsfrom Science DailyTue, 5 Jul 2011, 14:31:04 UTC
- PET scan with [11C]erlotinib may provide noninvasive method to identify TKI-responsive lung tumorsfrom PhysorgTue, 5 Jul 2011, 9:00:23 UTC
- ALK rearrangement found in nearly 10 percent of patients in Lung Cancer Mutation Consortiumfrom PhysorgTue, 5 Jul 2011, 9:00:22 UTC
- Lung tumors in never-smokers show greater genomic instability than those in smokersfrom PhysorgTue, 5 Jul 2011, 9:00:22 UTC
- High EGFR expression a predictor for improved survival with cetuximab plus chemotherapyfrom PhysorgTue, 5 Jul 2011, 9:00:21 UTC
- EURTAC Phase III study: Erlotinib nearly doubles progression-free survival vs. chemotherapyfrom PhysorgTue, 5 Jul 2011, 9:00:20 UTC